Clinical Trial Update: Compare FOFLOX4 in Preoperative and Postoperative and Postoperative in Resectable Liver Metastasis Colorectal Cancer (MCC) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating FOFLOX4 for resectable colorectal liver metastases in colorectal cancer. Current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Liver Metastases

Drugs mentioned

• FOFLOX4

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Colorectal Cancer, Liver Metastasis | Phase 3 | Status: UNKNOWN